Literature DB >> 26553058

Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.

Maryam Rezazadeh1, Aziz Khorrami1, Tarlan Yeghaneh1, Mahnaz Talebi2, Seyed Jalal Kiani3, Yaser Heshmati4, Jalal Gharesouran5.   

Abstract

Alzheimer's disease is considered a progressive brain disease in the older population. Late-onset Alzheimer's disease (LOAD) as a multifactorial dementia has a polygenic inheritance. Age, environment, and lifestyle along with a growing number of genetic factors have been reported as risk factors for LOAD. Our aim was to present results of LOAD association studies that have been done in northwestern Iran, and we also explored possible interactions with apolipoprotein E (APOE) status. We re-evaluated the association of these markers in dominant, recessive, and additive models. In all, 160 LOAD and 163 healthy control subjects of Azeri Turkish ethnicity were studied. The Chi-square test with Yates' correction and Fisher's exact test were used for statistical analysis. A Bonferroni-corrected p value, based on the number of statistical tests, was considered significant. Our results confirmed that chemokine receptor type 2 (CCR2), estrogen receptor 1 (ESR1), toll-like receptor 2 (TLR2), tumor necrosis factor alpha (TNF α), APOE, bridging integrator 1 (BIN1), and phosphatidylinositol-binding clathrin assembly protein (PICALM) are LOAD susceptibility loci in Azeri Turk ancestry populations. Among them, variants of CCR2, ESR1, TNF α, and APOE revealed associations in three different genetic models. After adjusting for APOE, the association (both allelic and genotypic) with CCR2, BIN1, and ESRα (PvuII) was evident only among subjects without the APOE ε4, whereas the association with CCR5, without Bonferroni correction, was significant only among subjects carrying the APOE ε4 allele. This result is an evidence of a synergistic and antagonistic effect of APOE on variant associations with LOAD.

Entities:  

Keywords:  APOE; Alzheimer’s disease; Association; Azeri Turkish; Neurodegenerative diseases; Polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26553058     DOI: 10.1007/s12017-015-8376-4

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  115 in total

1.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

2.  CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis.

Authors:  Ilhan Sezgin; Binnur Koksal; Gokhan Bagci; Hande Kucuk Kurtulgan; Ozturk Ozdemir
Journal:  Intern Med       Date:  2011-11-01       Impact factor: 1.271

3.  Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy.

Authors:  Carmela Rita Balistreri; Maria Paola Grimaldi; Sonya Vasto; Florinda Listi; Martina Chiappelli; Federico Licastro; Domenico Lio; Calogero Caruso; Giuseppina Candore
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

4.  Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.

Authors:  Cecilia Huerta; Victoria Alvarez; Ignacio F Mata; Eliecer Coto; René Ribacoba; Carmen Martínez; Marta Blázquez; Luis M Guisasola; Carlos Salvador; Carlos H Lahoz; Joaquín Peña
Journal:  Neurosci Lett       Date:  2004-11-11       Impact factor: 3.046

5.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

6.  Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb.

Authors:  Guo-Fang Lin; Qing-Wen Ma; Dong-Sheng Zhang; Yong-Lin Zha; Ke-Jian Lou; Jian-Hua Shen
Journal:  Acta Pharmacol Sin       Date:  2003-07       Impact factor: 6.150

7.  Molecular genetics of Alzheimer's disease and aging.

Authors:  Ramon Cacabelos; Lucia Fernandez-Novoa; Valter Lombardi; Yasuhiko Kubota; Masatoshi Takeda
Journal:  Methods Find Exp Clin Pharmacol       Date:  2005-07

8.  Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.

Authors:  Nobuto Shibata; Bolati Kuerban; Miwa Komatsu; Tohru Ohnuma; Hajime Baba; Heii Arai
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more
  9 in total

1.  A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer's Disease.

Authors:  Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Alvarez-Gonzalez; Idoia Martin-Guerrero; Marian M de Pancorbo; Africa Garcia-Orad; Elixabet Lopez-Lopez
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

Review 2.  Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.

Authors:  Leah Zuroff; David Daley; Keith L Black; Maya Koronyo-Hamaoui
Journal:  Cell Mol Life Sci       Date:  2017-02-14       Impact factor: 9.261

3.  Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer's Disease in Caucasian But Not Chinese population.

Authors:  Zhijie Han; Jiaojiao Qu; Jiehong Zhao; Xiao Zou
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

Review 4.  Cell Type Specific Expression of Toll-Like Receptors in Human Brains and Implications in Alzheimer's Disease.

Authors:  Henriette R Frederiksen; Henriette Haukedal; Kristine Freude
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

Review 5.  TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer's Disease: Lessons Learned from Transcriptomics.

Authors:  Feng Xue; Heng Du
Journal:  Cells       Date:  2021-02-04       Impact factor: 7.666

Review 6.  Role of Chemokines in the Development and Progression of Alzheimer's Disease.

Authors:  Jakub Wojcieszak; Katarzyna Kuczyńska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2022-07-12       Impact factor: 2.866

7.  Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability.

Authors:  Yuliya Voskobiynyk; Jonathan R Roth; J Nicholas Cochran; Travis Rush; Nancy Vn Carullo; Jacob S Mesina; Mohammad Waqas; Rachael M Vollmer; Jeremy J Day; Lori L McMahon; Erik D Roberson
Journal:  Elife       Date:  2020-07-13       Impact factor: 8.140

8.  Role of Microglia TLRs in Neurodegeneration.

Authors:  Bernd L Fiebich; Carla Ribeiro Alvares Batista; Soraya Wilke Saliba; Nizar M Yousif; Antonio Carlos Pinheiro de Oliveira
Journal:  Front Cell Neurosci       Date:  2018-10-02       Impact factor: 5.505

9.  Association of MS4A6A, CD33, and TREM2 gene polymorphisms with the late-onset Alzheimer's disease.

Authors:  Elham Mehdizadeh; Mohammad Khalaj-Kondori; Zeinab Shaghaghi-Tarakdari; Saeed Sadigh-Eteghad; Mahnaz Talebi; Sasan Andalib
Journal:  Bioimpacts       Date:  2019-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.